Melbourne Genomics' first clinical projects provided genomic sequencing to 315 patients of The Royal Melbourne Hospital and The Royal Children's Hospital. Our key findings regarding the Acute myeloid leukaemia project were:
Children (n=11) and adults (n=34, all aged under 70) with a form of blood cancer.
Almost half of adult patients had clinically-significant genomic results, suggesting the test may be useful.
Few genomic variants were found in child patients, suggesting the test is unlikely to provide more information than existing tests.